Enhancing API Dissolution Using Lipid-Based Solid-Dose Delivery

Tue Oct 19 2021 at 09:30 am to 10:30 am

Pennsylvania Convention Center | Philadelphia

JRS PHARMA
Publisher/HostJRS PHARMA
Enhancing API Dissolution Using Lipid-Based Solid-Dose Delivery
Advertisement
Enhancing API Dissolution Using Lipid-Based Solid-Dose Delivery
About this Event

Join Tony Carpanzano, Director of R&D at JRS PHARMA LP, at AAPS 2021 for an overview of an innovative new high functionality excipient designed for poorly soluble / highly lipophilic APIs.

Location:

Pennsylvania Convention Center | 360 Stage | Stage 2

Key Learning Objectives:

  • Understanding the challenges of enhancing drug dissolution
  • How this adsorbent binder simplifies the formulation of challenging APIs
  • How converting soft-gel capsules into tablets simplifies formulation development while providing economic benefits

Description:

Many drug compounds currently in development suffer from poor water solubility due to high lipophilicity. For these difficult APIs, formulators use various methods to enhance dissolution, most of which are costly and complex. This presentation provides an overview of a revolutionary adsorbent binder, where you’ll learn how it enhances the dissolution of poorly soluble drug compounds and how it can convert formulations of soft-gel capsules into tablets.

Advertisement

Event Venue & Nearby Stays

Pennsylvania Convention Center, 1101 Arch Street, Philadelphia, United States

Tickets

USD 0.00

Sharing is Caring: